US Stock MarketDetailed Quotes

Revelation Biosciences (REVB)

Watchlist
  • 0.8999
  • -0.0001-0.01%
Close Jan 15 16:00 ET
5.33MMarket Cap0.01P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revelation Biosciences (REVB) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
94.29%12.71M
-57.15%5.17M
-74.54%3.7M
-45.80%6.5M
-45.80%6.5M
-53.26%6.54M
-23.16%12.07M
-17.80%14.55M
128.28%11.99M
128.28%11.99M
-Cash and cash equivalents
94.29%12.71M
-57.15%5.17M
-74.54%3.7M
-45.80%6.5M
-45.80%6.5M
-53.26%6.54M
-23.16%12.07M
-17.80%14.55M
128.28%11.99M
128.28%11.99M
Prepaid assets
28.15%55.1K
9.25%75.16K
2,336.21%95.01K
-68.85%17.2K
-68.85%17.2K
-39.66%43K
-51.72%68.79K
-98.18%3.9K
--55.22K
--55.22K
Current deferred assets
----
----
----
--0
--0
--0
--0
--0
-18.40%71.13K
-18.40%71.13K
Other current assets
-8.04%68.83K
94.71%110.89K
88.68%128.26K
67.94%49.5K
67.94%49.5K
-8.03%74.85K
-47.03%56.95K
-42.70%67.98K
-59.69%29.48K
-59.69%29.48K
Total current assets
92.71%12.83M
-56.06%5.36M
-73.14%3.93M
-45.95%6.57M
-45.95%6.57M
-52.93%6.66M
-23.57%12.2M
-18.92%14.62M
124.40%12.15M
124.40%12.15M
Non current assets
Net PPE
-70.56%23.92K
-50.31%35.17K
-45.65%42.39K
-13.45%56.33K
-13.45%56.33K
13.87%81.24K
-8.81%70.77K
-7.01%77.99K
-27.79%65.08K
-27.79%65.08K
-Gross PPE
----
----
----
14.53%151.13K
14.53%151.13K
27.93%168.82K
14.53%151.14K
14.53%151.14K
0.00%131.96K
0.00%131.96K
-Accumulated depreciation
----
----
----
-41.75%-94.8K
-41.75%-94.8K
-44.48%-87.58K
-47.84%-80.36K
-52.08%-73.14K
-59.88%-66.88K
-59.88%-66.88K
Total non current assets
-70.56%23.92K
-50.31%35.17K
-45.65%42.39K
-13.45%56.33K
-13.45%56.33K
13.87%81.24K
-8.81%70.77K
-7.01%77.99K
-27.79%65.08K
-27.79%65.08K
Total assets
90.74%12.86M
-56.03%5.4M
-72.99%3.97M
-45.78%6.62M
-45.78%6.62M
-52.60%6.74M
-23.50%12.27M
-18.86%14.7M
121.91%12.21M
121.91%12.21M
Liabilities
Current liabilities
Payables
-66.91%1.03M
-35.31%828.89K
-62.83%625.06K
-42.38%783.62K
-42.38%783.62K
148.75%3.13M
40.21%1.28M
138.50%1.68M
145.38%1.36M
145.38%1.36M
-accounts payable
-66.91%1.03M
-35.31%828.89K
-62.83%625.06K
-42.38%783.62K
-42.38%783.62K
148.75%3.13M
40.21%1.28M
138.50%1.68M
145.38%1.36M
145.38%1.36M
Current accrued expenses
-12.31%819.38K
-91.25%739.63K
-25.25%463.63K
-2.14%1.13M
-2.14%1.13M
-8.58%934.37K
1,601.48%8.45M
-36.31%620.28K
16.94%1.15M
16.94%1.15M
Current deferred liabilities
----
----
----
--0
--0
--0
-52.50%1.38M
0.00%2.91M
0.00%2.91M
0.00%2.91M
Other current liabilities
-96.36%175
-92.75%786
-94.57%829
-98.41%2.25K
-98.41%2.25K
-97.71%4.8K
-96.41%10.84K
-99.57%15.26K
--141.28K
--141.28K
Current liabilities
-54.40%1.85M
-85.90%1.57M
-79.16%1.09M
-65.61%1.91M
-65.61%1.91M
-24.69%4.07M
140.68%11.13M
-35.46%5.23M
25.03%5.56M
25.03%5.56M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-54.40%1.85M
-85.90%1.57M
-79.16%1.09M
-65.61%1.91M
-65.61%1.91M
-24.69%4.07M
140.68%11.13M
-35.46%5.23M
25.03%5.56M
25.03%5.56M
Shareholders'equity
Share capital
-16.45%3.59K
-6.57%1.54K
-40.97%964
3,162.50%522
3,162.50%522
-31.84%4.29K
-73.91%1.64K
-65.48%1.63K
-79.22%16
-79.22%16
-common stock
-16.45%3.59K
-6.57%1.54K
-40.97%964
3,162.50%522
3,162.50%522
-31.84%4.29K
-73.91%1.64K
-65.48%1.63K
-79.22%16
-79.22%16
-Preferred stock
----
----
----
--0
--0
----
----
--0
--0
--0
Retained earnings
-20.96%-46.91M
-23.16%-45M
-51.19%-42.56M
-59.05%-40.51M
-59.05%-40.51M
-66.69%-38.78M
-77.06%-36.54M
-46.70%-28.15M
-0.47%-25.47M
-0.47%-25.47M
Paid-in capital
39.70%57.91M
29.59%48.83M
20.78%45.44M
40.79%45.21M
40.79%45.21M
29.22%41.45M
17.58%37.68M
28.83%37.62M
21.65%32.11M
21.65%32.11M
Total stockholders'equity
311.50%11M
235.47%3.83M
-69.59%2.88M
-29.17%4.71M
-29.17%4.71M
-69.68%2.67M
-90.01%1.14M
-5.44%9.47M
531.64%6.65M
531.64%6.65M
Total equity
311.50%11M
235.47%3.83M
-69.59%2.88M
-29.17%4.71M
-29.17%4.71M
-69.68%2.67M
-90.01%1.14M
-5.44%9.47M
531.64%6.65M
531.64%6.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 94.29%12.71M-57.15%5.17M-74.54%3.7M-45.80%6.5M-45.80%6.5M-53.26%6.54M-23.16%12.07M-17.80%14.55M128.28%11.99M128.28%11.99M
-Cash and cash equivalents 94.29%12.71M-57.15%5.17M-74.54%3.7M-45.80%6.5M-45.80%6.5M-53.26%6.54M-23.16%12.07M-17.80%14.55M128.28%11.99M128.28%11.99M
Prepaid assets 28.15%55.1K9.25%75.16K2,336.21%95.01K-68.85%17.2K-68.85%17.2K-39.66%43K-51.72%68.79K-98.18%3.9K--55.22K--55.22K
Current deferred assets --------------0--0--0--0--0-18.40%71.13K-18.40%71.13K
Other current assets -8.04%68.83K94.71%110.89K88.68%128.26K67.94%49.5K67.94%49.5K-8.03%74.85K-47.03%56.95K-42.70%67.98K-59.69%29.48K-59.69%29.48K
Total current assets 92.71%12.83M-56.06%5.36M-73.14%3.93M-45.95%6.57M-45.95%6.57M-52.93%6.66M-23.57%12.2M-18.92%14.62M124.40%12.15M124.40%12.15M
Non current assets
Net PPE -70.56%23.92K-50.31%35.17K-45.65%42.39K-13.45%56.33K-13.45%56.33K13.87%81.24K-8.81%70.77K-7.01%77.99K-27.79%65.08K-27.79%65.08K
-Gross PPE ------------14.53%151.13K14.53%151.13K27.93%168.82K14.53%151.14K14.53%151.14K0.00%131.96K0.00%131.96K
-Accumulated depreciation -------------41.75%-94.8K-41.75%-94.8K-44.48%-87.58K-47.84%-80.36K-52.08%-73.14K-59.88%-66.88K-59.88%-66.88K
Total non current assets -70.56%23.92K-50.31%35.17K-45.65%42.39K-13.45%56.33K-13.45%56.33K13.87%81.24K-8.81%70.77K-7.01%77.99K-27.79%65.08K-27.79%65.08K
Total assets 90.74%12.86M-56.03%5.4M-72.99%3.97M-45.78%6.62M-45.78%6.62M-52.60%6.74M-23.50%12.27M-18.86%14.7M121.91%12.21M121.91%12.21M
Liabilities
Current liabilities
Payables -66.91%1.03M-35.31%828.89K-62.83%625.06K-42.38%783.62K-42.38%783.62K148.75%3.13M40.21%1.28M138.50%1.68M145.38%1.36M145.38%1.36M
-accounts payable -66.91%1.03M-35.31%828.89K-62.83%625.06K-42.38%783.62K-42.38%783.62K148.75%3.13M40.21%1.28M138.50%1.68M145.38%1.36M145.38%1.36M
Current accrued expenses -12.31%819.38K-91.25%739.63K-25.25%463.63K-2.14%1.13M-2.14%1.13M-8.58%934.37K1,601.48%8.45M-36.31%620.28K16.94%1.15M16.94%1.15M
Current deferred liabilities --------------0--0--0-52.50%1.38M0.00%2.91M0.00%2.91M0.00%2.91M
Other current liabilities -96.36%175-92.75%786-94.57%829-98.41%2.25K-98.41%2.25K-97.71%4.8K-96.41%10.84K-99.57%15.26K--141.28K--141.28K
Current liabilities -54.40%1.85M-85.90%1.57M-79.16%1.09M-65.61%1.91M-65.61%1.91M-24.69%4.07M140.68%11.13M-35.46%5.23M25.03%5.56M25.03%5.56M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -54.40%1.85M-85.90%1.57M-79.16%1.09M-65.61%1.91M-65.61%1.91M-24.69%4.07M140.68%11.13M-35.46%5.23M25.03%5.56M25.03%5.56M
Shareholders'equity
Share capital -16.45%3.59K-6.57%1.54K-40.97%9643,162.50%5223,162.50%522-31.84%4.29K-73.91%1.64K-65.48%1.63K-79.22%16-79.22%16
-common stock -16.45%3.59K-6.57%1.54K-40.97%9643,162.50%5223,162.50%522-31.84%4.29K-73.91%1.64K-65.48%1.63K-79.22%16-79.22%16
-Preferred stock --------------0--0----------0--0--0
Retained earnings -20.96%-46.91M-23.16%-45M-51.19%-42.56M-59.05%-40.51M-59.05%-40.51M-66.69%-38.78M-77.06%-36.54M-46.70%-28.15M-0.47%-25.47M-0.47%-25.47M
Paid-in capital 39.70%57.91M29.59%48.83M20.78%45.44M40.79%45.21M40.79%45.21M29.22%41.45M17.58%37.68M28.83%37.62M21.65%32.11M21.65%32.11M
Total stockholders'equity 311.50%11M235.47%3.83M-69.59%2.88M-29.17%4.71M-29.17%4.71M-69.68%2.67M-90.01%1.14M-5.44%9.47M531.64%6.65M531.64%6.65M
Total equity 311.50%11M235.47%3.83M-69.59%2.88M-29.17%4.71M-29.17%4.71M-69.68%2.67M-90.01%1.14M-5.44%9.47M531.64%6.65M531.64%6.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -